HEB, Hemispherx Biopharma (AMEX)NEW Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mama Bear who wrote (563)	11/5/1998 12:53:00 PM
From: Anthony@Pacific	of 857

I for one think asensio is an arrogant and idiotic trader if he believes that disclosing his short-interest will do any thing but cause the " Short buster type trader" to take a whack at forcing a squeeze...which we have seen,, the company on the other hand are even bigger criminals and have defacated all over the FDA process and the discretion they are supposed to exhibit..Ampligen is clearly a useless and ineffective drug which HEB has no exclusivity to control; This published report still holds true... dripadvisor.com The points made about the orphan drug status are very much true and if any real market actually ever developed HEB would have this revoked,, by the way anyone have an idea as to when we might see the Phase 3 trials near completion..It is in the best interest of the Company to never finish them...so they can keep the stock afloat. Asensio has done a true dis-service to himself and those who know and believe this is a complete scam.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next